Single-use Bioprocessing Systems Market is Expanding Rapidly with Sartorius AG launching BIOSTAT STR Generation 3 with BioBrain to make biopharmaceutical development and production faster and safer
Single-use bioprocessing systems are
designed for faster manufacturing as well as to save floor space. These systems
are designed to be used once and thereafter discarded. Generally, these devices
are comprised of plastic components that have been sealed and sterilized using
gamma radiation. Most single-step bioprocess systems are used by medical
facilities for the transportation of biological products and waste materials,
such as blood, urine, saliva, urine, blood components, and other. These
products are normally shipped in containers that are transported through
multiple processes, such as by conveyor and by air. Such containers can be
expensive to purchase.
Increasing demand for
biopharmaceuticals is expected to drive growth of the global single-use
bioprocessing systems market. Biopharmaceuticals are medicinal products
manufactured in extracted or semi-synthesized from biological sources such as
animals, humans, and microorganisms and are mainly used in drug development or
as therapeutic agents such as vaccines, cell therapies, and more. Rising demand
for biopharmaceuticals has led to increase in R&D activities. For instance,
in December 2020, IDBS, a software informatics solution provider, launched
Polar, a new product category that aims to streamline and boost
biopharmaceutical developments. Hence, such factors are expected to drive
growth of the global single-use bioprocessing systems market. Furthermore,
faster implementation of and lower risk of product cross-contamination is
expected to propel the global single-use bioprocessing systems market growth in
the near future.
Challenges regarding extractable and
leachable combined with waste disposable difficulties are expected to hamper
the global single-use bioprocessing systems market growth in the near future.
However, untapped potential in emerging economies can provide major business
opportunities in the global single-use bioprocessing systems market in the near
future. Among regions, North America is expected to witness significant growth
in the global single-use bioprocessing systems market. This is owing to the
presence of large-scale biopharmaceutical manufacturing facilities such as
Meissner Filtration Products, Inc., GE Healthcare, and ThermoFisher Scientific
in the region. Furthermore, Asia Pacific is expected to register a robust
growth rate, owing to rising government initiatives in the field of
biopharmaceutical sectors.
Key players involved in the global
single-use bioprocessing systems market are Meissner Filtration Products, Inc.,
Pall Corporation, Sartorius AG, Merck KGaA, Eppendorf AG, Rentschler Biopharma
SE, General Electric Company (GE Healthcare), ThermoFisher Scientific, and
Corning Inc.
For instance, in March 2020,
Sartorius AG launched BIOSTAT STR Generation 3 with BioBrain to make
biopharmaceutical development and production faster and safer.

Comments
Post a Comment